Search Results for 'her2'
her2 published presentations and documents on DocSlides.
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer
by danika-pritchard
ASCO-CAP Recommendations For HER2 Testing in Brea...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ
by carny
Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...
HER2 and Ki67Assessment of regional lymph nodesPhysical examination
by arya
Luminal B-like (HER2-positive):!ER-positive!HER2-p...
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Changes in Breast Cancer Reports After Second Opinion
by unita
Dr. Vicente Marco. Department of Pathology. Hospit...
Antibody–Drug Conjugates in Development for Non-
by elizabeth
s. mall Cell . Lung Cancer. , Gastric Cancer, and ...
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
by gelbero
Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...
Denise A. Yardley, MD Sarah Cannon Research Institute
by lily
Senior Investigator, . Breast Cancer Research. Ten...
2020 Year in Review: Breast Cancer
by caroline
Lisa A. Carey MD, . ScM. University of North Carol...
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
Mauricio Lema Medina – ClĂnica de OncologĂa Astorga / ClĂnica SOMA, MedellĂn
by delcy
Trastuzumab-emtansine. : A . very. . nice. . poi...
What’s new in Anatomic Pathology Quality Assurance?
by alida-meadow
. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...
Tumor Marker Phenotype Concordance in Second Primary Breast Cancer
by debby-jeon
Monica Brown, MPH, PhD. . California Cancer Regi...
Metastatic Breast Cancer: A Medical Update
by liane-varnes
Jennifer M. Matro, MD. Rena Rowan Breast Center. ...
Updates in the Treatment of Breast cancer
by alexa-scheidler
Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. UniversitĂ di Napoli Federico II. ...
6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im
by katrgolden
Contents PageIntended Use 4Summary and Explanation...
Snyder D, Heidel RE, Panella T, Bell J, Orucevic
by Kingslayer
A. University of Tennessee Medical Center – Knox...
20 March 2014EMACHMP1518532014Committee for Medicinal Products for
by nicole
Adoptedby CHMPfor release for consultation20 March...
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Chemotherapeutic Treatment Options for Triple Negative Breast Cancer
by iris
Lauren Barney. April 17, 2013. Breast Cancer Subty...
Breast Cancer in Older Patients
by ButterflyKisses
Key Issues. Etienne GC . Brain. , MD . PhD. Instit...
Use specific response toward environment as a selective marker for therapy in breast cancer cells.
by BraveButterfly
Hsiu. -Ni Kung. Anatomy and Cell Biology, Medical ...